122 related articles for article (PubMed ID: 17383286)
21. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.
Sinnaeve PR; Steg PG; Fox KA; Van de Werf F; Montalescot G; Granger CB; Knobel E; Anderson FA; Dabbous OH; Avezum A;
Arch Intern Med; 2009 Feb; 169(4):402-9. PubMed ID: 19237725
[TBL] [Abstract][Full Text] [Related]
22. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
Tricoci P; Lokhnygina Y; Berdan LG; Steinhubl SR; Gulba DC; White HD; Kleiman NS; Aylward PE; Langer A; Califf RM; Ferguson JJ; Antman EM; Newby LK; Harrington RA; Goodman SG; Mahaffey KW
Circulation; 2007 Dec; 116(23):2669-77. PubMed ID: 18025532
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
[TBL] [Abstract][Full Text] [Related]
24. Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry).
Abbott JD; Ahmed HN; Vlachos HA; Selzer F; Williams DO
Am J Cardiol; 2007 Jul; 100(2):190-5. PubMed ID: 17631068
[TBL] [Abstract][Full Text] [Related]
25. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
[TBL] [Abstract][Full Text] [Related]
26. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry).
Kuch B; von Scheidt W; Kling B; Heier M; Hoermann A; Meisinger C
Am J Cardiol; 2008 Nov; 102(9):1125-30. PubMed ID: 18940277
[TBL] [Abstract][Full Text] [Related]
27. Trends in outcomes among older patients with non-ST-segment elevation myocardial infarction.
Chin CT; Wang TY; Chen AY; Mathews R; Alexander KP; Roe MT; Peterson ED
Am Heart J; 2014 Jan; 167(1):36-42.e1. PubMed ID: 24332140
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of types of atrial fibrillation in acute coronary syndromes.
Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P
Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044
[TBL] [Abstract][Full Text] [Related]
29. Patients with non-ST-elevation myocardial infarction and without chest pain are treated less aggressively and experience higher in-hospital mortality.
Zdzienicka J; Siudak Z; Zawiślak B; Dziewierz A; Rakowski T; Dubiel J; Dudek D
Kardiol Pol; 2007 Jul; 65(7):769-75; discussion 776-7. PubMed ID: 17694458
[TBL] [Abstract][Full Text] [Related]
30. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.
Pride YB; Appelbaum E; Lord EE; Sloan S; Cannon CP; Sabatine MS; Gibson CM;
Am J Cardiol; 2009 Aug; 104(4):475-9. PubMed ID: 19660597
[TBL] [Abstract][Full Text] [Related]
31. Antiplatelet therapy in patients with unstable angina and non-ST-segment-elevation myocardial infarction: findings from the CRUSADE national quality improvement initiative.
Bottorff MB; Nutescu EA; Spinler S
Pharmacotherapy; 2007 Aug; 27(8):1145-62. PubMed ID: 17655514
[TBL] [Abstract][Full Text] [Related]
32. ST-segment elevation myocardial infarction due to early and late stent thrombosis a new group of high-risk patients.
Chechi T; Vecchio S; Vittori G; Giuliani G; Lilli A; Spaziani G; Consoli L; Baldereschi G; Biondi-Zoccai GG; Sheiban I; Margheri M
J Am Coll Cardiol; 2008 Jun; 51(25):2396-402. PubMed ID: 18565395
[TBL] [Abstract][Full Text] [Related]
33. ST-segment deviation on the admission electrocardiogram, treatment strategy, and outcome in non-ST-elevation acute coronary syndromes A substudy of the Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) Trial.
Windhausen F; Hirsch A; Tijssen JG; Cornel JH; Verheugt FW; Klees MI; de Winter RJ;
J Electrocardiol; 2007; 40(5):408-15. PubMed ID: 17604045
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of kidney function in patients with ST-elevation and non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention.
Seyfarth M; Kastrati A; Mann JF; Ndrepepa G; Byrne RA; Schulz S; Mehilli J; Schömig A
Am J Kidney Dis; 2009 Nov; 54(5):830-9. PubMed ID: 19592145
[TBL] [Abstract][Full Text] [Related]
35. Obesity and age of first non-ST-segment elevation myocardial infarction.
Madala MC; Franklin BA; Chen AY; Berman AD; Roe MT; Peterson ED; Ohman EM; Smith SC; Gibler WB; McCullough PA;
J Am Coll Cardiol; 2008 Sep; 52(12):979-85. PubMed ID: 18786477
[TBL] [Abstract][Full Text] [Related]
36. Guideline implementation research: exploring the gap between evidence and practice in the CRUSADE Quality Improvement Initiative.
Blomkalns AL; Roe MT; Peterson ED; Ohman EM; Fraulo ES; Gibler WB
Acad Emerg Med; 2007 Nov; 14(11):949-54. PubMed ID: 17967956
[TBL] [Abstract][Full Text] [Related]
37. Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland.
Poloński L; Gasior M; Gierlotka M; Kalarus Z; Cieśliński A; Dubiel JS; Gil RJ; Ruzyłło W; Trusz-Gluza M; Zembala M; Opolski G
Kardiol Pol; 2007 Aug; 65(8):861-72; discussion 873-4. PubMed ID: 17853315
[TBL] [Abstract][Full Text] [Related]
38. Impact of body mass index and waist-to-hip ratio on clinical outcomes in patients with ST-segment elevation acute myocardial infarction (from the Korean Acute Myocardial Infarction Registry).
Lee SH; Park JS; Kim W; Shin DG; Kim YJ; Kim DS; Choi DJ; Han KR; Kim CJ; Cho MC; Chae SC; Jeong MH;
Am J Cardiol; 2008 Oct; 102(8):957-65. PubMed ID: 18929693
[TBL] [Abstract][Full Text] [Related]
39. Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome.
Leung S; Gallup D; Mahaffey KW; Cohen M; Antman EM; Goodman SG; Harrington RA; Langer A; Aylward P; Ferguson JJ; Califf RM;
Am Heart J; 2008 Jul; 156(1):177-84. PubMed ID: 18585514
[TBL] [Abstract][Full Text] [Related]
40. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality.
Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
Circulation; 2007 Oct; 116(17):1907-14. PubMed ID: 17909103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
